National Tuberculosis Control Program in Bangladesh : Progress Report Dr. Shamim Sultana Deputy Programme Manager, TB National TB Control Programme.

Slides:



Advertisements
Similar presentations
DOTS/ DOTS PLUS IMPLEMENTATION AND INTEGRATION Vaira Leimane State Centre of Tuberculosis and Lung Diseases of Latvia Paris, October, 28.
Advertisements

Planning in line with the Stop TB Strategy and the Global Plan to Stop TB, Dr Win Maung Programme Manager National Tuberculosis Programme Ministry.
From DOTS to the Stop TB Strategy Building on Achievements for Future Planning Stop TB Partnership Symposium at the 37 th UNION World Conference on TB.
PPM-DOTS in Cambodia Working with Private Pharmacies DOTS Expansion WG Meeting Paris 15 th October 2008 Dr. Mao Tan Eang Director National Center for TB.
Improving diagnosis TB laboratory strengthening.
Ram Deo Chaudhary Programme Manager, BNMT. Outlines VMGO of BNMT Guiding principles of partnership Historical background Current efforts Strengths Area.
Accelerating PMDT scale up in Ethiopia
GUIDELINES & TOOLS for HOSPITAL DOTS LINKAGE (HDL)
Dr R.Reesaul Chest Physician Chest Clinic P. D`or Hospital
Introduction Thailand one of 22 countries which contain 80% of the estimated tuberculosis (TB) cases in the world. Thailand ranks 17 th among the 22 high-burden.
Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Revised National Tuberculosis Control Programme (RNTCP)
Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.
National TB/ Leprosy Programme Manager
Action Plan Prepared by : Ismat Ara Khusheed Deputy Director,PTP Sindh At JAPAN 2006 At JAPAN 2006.
1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova.
CITAM+ Engaging HIV Civil Society in TB ACSM Meeting, Cancun 30 Nov 2009 Carol Nawina Nyirenda National Coordinator Community Initiative for TB, HIV/AIDS.
Accelerating TB/HIV activities in Zambia Alwyn Mwinga 2007 HIV Implementers Meeting 20 June 2007.
Tools for HIV/TB Integration and the Civil Society Experience Carol Nawina Nyirenda Executive Director Community Initiative for Tuberculosis, HIV/AIDS.
African Business Leaders on Health GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 2010 Technical Assistance.
NGO-Collaboration: lessons learned and way forward Faruque Ahmed Director, Health and Nutrition Program BRAC.
Unit 9. Human resource development for TB infection control TB Infection Control Training for Managers at National and Subnational Level.
RNTCP: DOTS Expansion and plans for DOTS-Plus
Challenge 4: Linking TB & HIV/AIDS Programs Kayt Erdahl, Project HOPE Rodrick Nalikungwi, Project HOPE Malawi December 18, 2008.
1 TB/HIV Project in the Philippines Yumiko Yanase.
Framework and Standards for Effective TB Control Module 3 – March 2010
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
Mongolia Progress Report Dr. D. Otgontsetseg, Head of recording and reporting unit, TB surveillance and research department, NCCD The ninth Technical Advisory.
Tajikistan The Global Fund to Fight AIDS, Tuberculosis and Malaria Support to the Strategic Plan to Prevent HIV/AIDS Epidemics in Tajikistan. November.
COUNTRY ACTION: SUSTAINABLE INVESTMENT STOP TB PARTNERSHIP FORUM STOP TB PARTNERSHIP FORUM 24TH-26TH MARCH TH-26TH MARCH 2004 BY BY MRS NENADI USMAN.
Progress and Plans for PPM in the Western Pacific Region Fifth PPM DOTS Subgroup Meeting Cairo, Egypt.
“World TB day and TB in Mongolia”
Action Plan Good Health Situation of Population in Capital of Myanmar Yangon Division By DR MYA THIDA AYE.
TB PUBLIC-PRIVATE MIX DOTS Dr. Team Bakkhim Deputy Director CENAT Intercontinental Hotel 7 th November, 2012 NATIONAL FORUM ON PUBLIC-PRIVATE PARTNERSHIP.
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
Japan Dr. Ismail M. Aboshama Zidan Surveillance Coordinator of NTP-Egypt Action Plan to Strengthen Laboratory Diagnostic.
Pioneering IMAI: Developing an integrated approach in Uganda Dr Elizabeth Madraa, Program Manager National STD/AIDS Control Program MOH - UGANDA 5 th Dec.
TB/HIV COLLABORATION IN GHANA Dr. Nii Nortey Hanson – Nortey National TB Control Programme Accra.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
1 DEWG meeting October 2009 Human Resource Development for TB Control (HRD-TB) Sub Group within the DEWG of the Stop TB Partnership. Wanda Walton.
Yoana Anandita NTP Indonesia ACSM Sub Group Meeting 30 Nov-1 Dec 2009.
PERSPECTIVES FROM THE FIELD DR LYDIA MUNGHERERA TASO (The Aids Support Organisation) UGANDA REVERSING THE TIDE OF TB.
Meeting of the Working Group on TB Drug Development Why you need to be engaged? Marcos Espinal Executive Secretary Stop TB Partnership 29 October 2004.
Contribution of operational research in China National Center for TB Control and Prevention, China CDC Jiang Shiwen Cancun.
Dr Ral Antic Chair Scientific Committee IUATLD-APR Australia Pre-Conference Workshop 1 National TB Control Program Summary & Remarks.
PARTNERSHIP FOR TB CARE AND CONTROL IN INDIA Inception : The Partnership has its roots in a Round 8 proposal for the Global Fund. In August 2008, USAID.
Introducing fixed dose combination tablets into DR CONGO using the Global TB Drug Facility.
Global Fund Grant Proposal Round 11: Tuberculosis Nathan Furukawa Gabriella Boyle Rebekah Miner Paa Kobina Forson Xiaoxue Huang Hunter Pugh Gap Analysis.
Outline of Current Situation Survey on HIV/AIDS (Proposal) Ms. Keiko Dozono Director for AIDS and Emerging Infectious Disease Control Health and Safety.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Challenges and Constraints for TB Control in Kenya Dr. James Nyikal Director of Medical Services, Kenya.
Stop TB in China Challenges, Constraints & Actions Dr Wang Longde Vice Minister of Health China 24 March 2004.
TB- HIV Collaborative activities in Romania- may 2006 status
Prisons and TB in Europe
Country Progress Report Cambodia
TB Control in PHC network and Partners Coordination in Cambodia
TB/HIV surveillance : Who is going to get the job done?
Key issues in DOTS implementation
Impact of Using Fixed Dose Combinations (FDCs) versus
Impact of Using Fixed Dose Combinations (FDCs) versus
Update on SBCC Activities of Challenge TB Bangladesh
Objectives of Session Provide an overview of the development of Compendium Explain the organization of the Compendium and how indicators are used Provide.
Vietnam Investment and Finance for TB
TB epidemiological situation in Kyrgyzstan
From TB control to integrated respiratory disease control
5th DEWG meeting Conclusions
South Africa: From ProTest to Nationwide Implementation
The STOP TB Strategy – 2009 VISION: A TB-free world
Presentation transcript:

National Tuberculosis Control Program in Bangladesh : Progress Report Dr. Shamim Sultana Deputy Programme Manager, TB National TB Control Programme Directorate General of Health Services Mohakhali, Dhaka

BANGLADESH: Country Profile Situated in South Asia Population : 140.70 million (2006 projected estimate, based on 2001 Census) Area: 147,570 sq. km Density: 953 per km2 GNP per capita: 444 US$ Administratively, it has- Division: 6 District: 64 Sub District: 507

BANGLADESH: TB Situation 5th among 22 high TB burden countries ARTI: 2.14% 50% of adult population infected Estimated new cases of TB (all forms) per year : 227 / 100000 population Estimated new smear positive TB cases per year: 102/ 100000 population TB Prevalence (all cases): 406/100000 pop

BANGLADESH: TB Situation TB Mortality ( all cases per year) : 47/100000 population Percent estimated new adult cases of TB co-infected with HIV : 0.1% No representative DRS data available Estimated New TB cases MDR: 1.8% Estimated previously treated TB Cases MDR: 14%

BANGLADESH: TB Situation DOTS strategy- implemented in November 1993 DOTS Coverage: almost 99% TB Case Detection Rate 2006: 71.06% Treatment Success Rate ( 2005): 91.51% Source: WHO estimates of 2006

BANGLADESH: TB Situation TB Case Detection Rates: (2006) National : 71.06% Divisional : Dhaka 68.0% Chittagong 75.0% Rajshahi 61.4% Khulna 75.6% Barisal 90.9% Sylhet 81.8%

Smear +ve Cases: Treatment Success and Case Detection Rates (%); Since 1993

TB Situation from 2004 - 2006 General/All cases in 2004 Year 2004 2005 2006 Country Population: 137 million 140 million 140.7 million DOTS population coverage (%): 99% Number of TB cases notified (all cases): 90,741 122,907 145,164 % Detection*: 31% 32% 45.07% Number of pulmonary TB sputum-smear positive case: 62,228 88,576 101,988 46% 61% 71.06% Success rate of smear positive cases (%)[cure plus completion] : 89% 91.51% Please fill in table for 2002 and 2003. *Percentage of cases notified out of estimated cases

TB Situation of 2006 Reporting Unit Pulmonary Positive Upazilla 75.51 Pulmonary Negative % Extra Pulmonary New Total New Relapse Upazilla 75.51 2.23 14.07 8.19 82 Metro 47.87 6.58 27.54 18.01 13 CDC 42.97 4.23 35.24 17.57 5 70.26 2.90 16.89 9.95 100

Vision and Mission of NTP Tuberculosis is no more a public health problem in Bangladesh MISSION: National Tuberculosis Program (NTP) aims to strengthen the effort of TB Control through effective partnership, mobilizing resources and ensuring quality diagnostic and treatment services under defined Directly Observed Treatment Short Course (DOTS) strategy. The service should be equally available to all people of Bangladesh irrespective of age, sex, religion, ethnicity, social status and race.

Vision and Mission of NTP (Cont.) GOALS OF NATIONAL TB CONTROL PROGRAM The overall goal of TB control is to reduce morbidity, mortality and transmission of TB until it is no longer a public health problem

Vision and Mission (Cont.) OBJECTIVES OF NATIONAL TB CONTROL PROGRAM - Reach and thereafter sustain the 2005 targets- achieving at least 70% case detection and 85% treatment success among TB cases under DOTS In order to then, - Reach the interim target of halving TB death and prevalence achieving the Millennium Development Goals set by 2015

Areas of GO-NGO Collaboration in TB Control in Bangladesh Area of Collaboration Government NGOs/ Partners Implementation Policy, Planning and Budgeting National guidelines Overall coordination Infrastructure Specific areas as per MoU Case finding and Case Holding Equipment/supplies Diagnosis, Treatment, DOT , Follow-up, Management of complicated cases Referral centres Suspect identification, Referral for Diagnosis, Diagnosis and Treatment, DOT and Follow-up Training Training of Trainers (TOT) Responsible for pertaining all forms of training/ orientation to all categories of GoB and NGOs/ Partners Local training only for respective NGO staff as per NTP curricula, support government training

Areas of GO-NGO Collaboration in TB Control in Bangladesh (Contd.) Area of Collaboration Government NGOs/ Partners Drugs and Logistics Management Central procurement Distribution Local storage Local storage and distribution Supply indent Monitoring ,Supervision and Evaluation Recording and Reporting Overall Monitoring and Supervision External and Internal Evaluation Local Monitoring and Supervision Participate in internal and external evaluation Advocacy, Communication and Social Mobilization (ACSM) Policy, Planning and Budgeting Advocacy meetings with all stakeholders National campaigns Outreach activities at local community

ROLE OF THE NTP AND ITS IMPLEMENTING PARTNERS AT DIFFERENT LEVELS Partners/Implementing agencies NTP Central Level Responsible Persons: Director- MBDC & Line Director-TB/Leprosy, Deputy Director-MBDC , Asst. Director, Program Manager-TB, DPM-TB and MOs Responsibilities: Policy formulation, Planning, Budgeting, Coordination with partners,Operational Guidelines, HRD, ACSM, EQA, Procurement and Supply of Drug and Logistics, MIS, Supervision, Monitoring & Evaluation and Operational Research Responsible Bodies: Academic Institutes, NGOs and Professional Associations Responsibilities: Civil society and private sector involvement,ACSM,Recording and Reporting, Supervision and Monitoring, Implementation of Operational Research

ROLE OF THE NTP AND ITS IMPLEMENTING PARTNERS AT DIFFERENT LEVELS (Contd.) Partners/Implementing agencies NTP Responsible Persons: Divisional Director Health and Deputy Director, Health. Responsibilities: Supervision and Monitoring according to NTP guidelines, coordination with NTP and partners Divisional level Responsible Bodies: City Corporations, NGOs, Chest Hospitals, Academic Institutes, Corporate Health Services, Private Sectors and Prisons. Responsibilities: Implementing DOTS, Management of referred cases,ACSM, Recording and Reporting , Supervision and Monitoring Responsible Persons: Civil Surgeon Consultant-Chest Disease Clinic, MO and PO- TB-LEP Responsibilities: Supervision, Monitoring and Evaluation, EQA,Training, technical guidance, coordination with NTP partners and implementing DOTS District Level Responsible Bodies: Academic Institutions, District Hospitals, Chest Disease Clinics, NGOs. Responsibilities: DOTS Implementation, Management of referred cases, Supervision, Monitoring, Quality Assurance, networking with private providers, ACSM,Recording and Reporting, indenting for drugs and logistics.

ROLE OF THE NTP AND ITS IMPLEMENTING PARTNERS AT DIFFERENT LEVELS (CONT.) Partners/Implementing agencies NTP Responsible Persons:UH&FPO, MO LTCA Responsibilities: Implementation of DOTS, Supervision, Monitoring and Evaluation, Training, Recording and Reporting, Coordination with NTP partners Responsible Bodies: UHC, NGO partners Responsibilities: Identification of suspects, sputum collection and examination, Training, ACSM, DOT,Follow Up, Supervision, Recording and Reporting, and Indenting drugs and logistics Upazila Level

ROLE OF THE NTP AND ITS IMPLEMENTING PARTNERS AT DIFFERENT LEVELS (Contd.) Partners/Implementing agencies NTP Responsible Persons: HI,AHI, HA, MA Responsibilities: ACSM, Suspect identification and referral, DOT, Follow Up Responsible Bodies: Health sub-centers, NGO partners. Responsibilities:ACSM, Suspect identification and referral, DOT, Follow Up,Sputum collection and transportation to laboratory Union/ward Level Village Level Responsible Persons: Community Health Workers (Shastho Shebikas), Village Doctors, Cured patients Responsibilities: Suspect identification and referral, DOT, Follow Up

National / International Partnerships (list of institution) Type of Partnership 1. NGOs (BRAC, LTCC UPHCP, NSDP) DOTS Service Delivery 2.NATAB Civil Society Involvement in TB Control 3. ICDDR,B Operations Research 4. Private Practitioners DOTS Service Delivery and Collaborate With NTP NGO Partners 5. Academic Institutes, Public and Private Hospitals DOTS Service Delivery, Referral Centres Please identify all country partnerships, including financial/donor, technical, NGO, local agency, medical society, etc.

National / International Partnerships( Cont.) (list of institution) Type of Partnership 6. Corporate Sectors, Work Places DOTS Service Delivery 7. Special Population ( Prison, Defences) 8. WHO Technical Assistance 9. GFATM, CIDA, USAID, JICA,WB Financial Assistance 10. RIT,KNCV,URC, IUATLD

Resource Mobilization :GFATM Grants (US$ in million) Principal Recipient Government NGO-BRAC Total Round 3 (Period: 2004-2009) 15.45 27.02 42.47 Round 5 (Period: 2006-2011) 26.45 19.52 45.97 41.9 46.54 88.44 Through this well established partnership Bangladesh was able to mobilize a significant amount of grant in 2004 and 2006 from the Global Fund to fight AIDS, TB and Malaria (GFATM) which gave momentum to the TB Control programme.

Current and Planned Activities Increase case detection and maintain high cure rates through strengthening DOTS services including quality of lab services Involve all health care providers Create demand for services through comprehensive advocacy, communication and social mobilization Strengthen the procurement and supply system Strengthen supervision, monitoring and evaluation Management of Multi Drug Resistant TB TB/HIV collaborative activities

NTP Achievements Expansion of DOTS in Metropolitan Cities Introduction of DOTS in prisons, academic institutions and workplaces Sustaining strong collaboration between Government and Non-Government organizations Access to the Global DOTS Expansion plan funded by CIDA, Global Drug Facility (GDF), Global Fund to Fight AIDS, TB and Malaria (GFATM) and strong technical support from WHO Please describe the 3 major achievements accomplished in 2003 toward reaching the 2005 global TB targets. Examples: DOTS has been expanded to 20 districts "x" number of hospitals started DOTS implementation Funding for TB control covers all needs expressed in the national plan

NTP Achievements(Cont.) 5. Detection of estimated new smear positive cases under NTP increased to over 70% in 2006 as compared to 34% in 2002 and treatment success rate to over 91% (2005) 6. Establishment of External Quality Assurance of smear microscopy 7. Initiation of Prevalence Survey Please describe the 3 major achievements accomplished in 2003 toward reaching the 2005 global TB targets. Examples: DOTS has been expanded to 20 districts "x" number of hospitals started DOTS implementation Funding for TB control covers all needs expressed in the national plan

NTP Achievements (Cont.) 8. Awareness campaigns initiated through mass media 9. Steps taken to function DRS and implementation of DOTS-Plus Project 10.Steps taken to implement PPM-DOTS, TB-HIV

Major Challenges Health Sector Reform Effective partnership to cover hard to reach/special areas: Private Hospitals and Clinics, Expansion in Defense Hospitals, Prisons, Brothels, Slums and Industrial Units, homeless population in difficult terrains Human Resource Capacity Development MDR-TB and HIV-TB Co infection Quality assurance of lab services Uninterrupted supply of drugs Strengthening of supervision and monitoring Dependence on external funding

THANK YOU